$FATE
FATE THERAPEUTICS INC

2019 Q1 Form 10-K Financial Statement

#000156459019006258 Filed on March 05, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2017 Q4 2017 Q3
Revenue $2.632M $1.027M $1.026M
YoY Change 156.53% 0.0% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.350M $3.380M $2.790M
YoY Change 48.61% 37.96% 6.9%
% of Gross Profit
Research & Development $17.73M $9.890M $8.578M
YoY Change 54.48% 58.75% 26.07%
% of Gross Profit
Depreciation & Amortization $440.0K $290.0K $240.0K
YoY Change 53.85% 45.0% 9.09%
% of Gross Profit
Operating Expenses $23.08M $13.27M $11.37M
YoY Change 53.04% 52.87% 20.72%
Operating Profit -$20.45M -$10.34M
YoY Change 23.26%
Interest Expense $405.0K -$250.0K $378.0K
YoY Change -606.25% -13.79% -1.82%
% of Operating Profit
Other Income/Expense, Net $686.0K
YoY Change
Pretax Income -$19.76M -$12.50M -$10.68M
YoY Change 39.75% 57.43% 22.2%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$19.76M -$12.50M -$10.68M
YoY Change 39.79% 57.39% 22.28%
Net Earnings / Revenue -750.76% -1216.85% -1041.33%
Basic Earnings Per Share
Diluted Earnings Per Share -$304.4K -$286.0K -$257.8K
COMMON SHARES
Basic Shares Outstanding 65.00M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2017 Q4 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $183.0M $100.9M $69.20M
YoY Change 106.55% 9.55% 48.5%
Cash & Equivalents $183.0M $88.95M $43.35M
Short-Term Investments $0.00 $12.00M $26.00M
Other Short-Term Assets $2.900M $1.600M $800.0K
YoY Change 93.33% 33.33% 0.0%
Inventory
Prepaid Expenses
Receivables $500.0K
Other Receivables $0.00
Total Short-Term Assets $186.4M $102.6M $70.00M
YoY Change 105.77% 9.94% 47.68%
LONG-TERM ASSETS
Property, Plant & Equipment $8.402M $2.550M $2.500M
YoY Change 223.15% 61.49% 38.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $24.00K $100.0K
YoY Change 100.0% 0.0% 0.0%
Total Long-Term Assets $34.47M $2.696M $2.700M
YoY Change 1131.07% 56.29% 42.11%
TOTAL ASSETS
Total Short-Term Assets $186.4M $102.6M $70.00M
Total Long-Term Assets $34.47M $2.696M $2.700M
Total Assets $220.9M $105.3M $72.70M
YoY Change 136.51% 10.78% 47.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.400M $1.678M $2.200M
YoY Change 145.45% 79.66% 83.33%
Accrued Expenses $11.20M $7.254M $5.400M
YoY Change 51.35% 83.32% 63.64%
Deferred Revenue $6.576M $2.105M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.941M $0.00 $0.00
YoY Change 392.63% -100.0% -100.0%
Total Short-Term Liabilities $29.14M $11.05M $9.700M
YoY Change 131.27% -27.25% -33.91%
LONG-TERM LIABILITIES
Long-Term Debt $10.96M $14.81M $14.80M
YoY Change -22.28% 492.08% 221.04%
Other Long-Term Liabilities $34.90M $2.200M $2.400M
YoY Change 1838.89% -47.62% -47.83%
Total Long-Term Liabilities $10.96M $14.81M $17.20M
YoY Change -31.08% 492.08% 273.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.14M $11.05M $9.700M
Total Long-Term Liabilities $10.96M $14.81M $17.20M
Total Liabilities $40.10M $25.86M $26.90M
YoY Change 41.19% 46.18% 39.46%
SHAREHOLDERS EQUITY
Retained Earnings -$305.2M -$218.8M
YoY Change 24.43%
Common Stock $65.00K $53.00K
YoY Change -99.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $145.8M $77.19M $45.75M
YoY Change
Total Liabilities & Shareholders Equity $220.9M $105.3M $72.70M
YoY Change 136.47% 10.78% 47.48%

Cashflow Statement

Concept 2019 Q1 2017 Q4 2017 Q3
OPERATING ACTIVITIES
Net Income -$19.76M -$12.50M -$10.68M
YoY Change 39.79% 57.39% 22.28%
Depreciation, Depletion And Amortization $440.0K $290.0K $240.0K
YoY Change 53.85% 45.0% 9.09%
Cash From Operating Activities -$17.49M -$10.81M -$9.770M
YoY Change 39.38% 43.18% 30.09%
INVESTING ACTIVITIES
Capital Expenditures $1.746M -$800.0K -$360.0K
YoY Change 848.91% 1900.0% 800.0%
Acquisitions
YoY Change
Other Investing Activities $10.50M $14.00M $14.00M
YoY Change -124.05% 132.56% 2757.14%
Cash From Investing Activities $8.754M $13.20M $13.64M
YoY Change -119.97% 120.74% 2865.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.258M 43.32M 8.300M
YoY Change 254.37% -18.4% 0.24%
NET CHANGE
Cash From Operating Activities -17.49M -10.81M -9.770M
Cash From Investing Activities 8.754M 13.20M 13.64M
Cash From Financing Activities 1.258M 43.32M 8.300M
Net Change In Cash -7.481M 45.71M 12.17M
YoY Change -86.65% -11.28% 889.43%
FREE CASH FLOW
Cash From Operating Activities -$17.49M -$10.81M -$9.770M
Capital Expenditures $1.746M -$800.0K -$360.0K
Free Cash Flow -$19.24M -$10.01M -$9.410M
YoY Change 51.07% 33.29% 25.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018 dei Trading Symbol
TradingSymbol
FATE
CY2018Q2 dei Entity Public Float
EntityPublicFloat
488652000
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64999547
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
190514000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88952000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
500000
CY2018Q4 fate Short Term Investments And Related Maturity Receivables
ShortTermInvestmentsAndRelatedMaturityReceivables
10493000
CY2017Q4 fate Short Term Investments And Related Maturity Receivables
ShortTermInvestmentsAndRelatedMaturityReceivables
11997000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3689000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1647000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
205196000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
102596000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5125000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2550000
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
227000
CY2017Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
122000
CY2018Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1958000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
526000
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24000
CY2018Q4 us-gaap Assets
Assets
213032000
CY2017Q4 us-gaap Assets
Assets
105292000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4205000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1678000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10926000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7254000
CY2018Q4 fate Cirm Award Liability Current
CIRMAwardLiabilityCurrent
2106000
CY2017Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
12000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7588000
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2105000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2438000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27263000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11049000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
3401000
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1347000
CY2017Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
724000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
549000
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
3000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
53000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
295934000
CY2016 fate Adjustments To Additional Paid In Capital Repurchase Liability For Unvested Equity Awards
AdjustmentsToAdditionalPaidInCapitalRepurchaseLiabilityForUnvestedEquityAwards
1000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3184000
CY2016 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34358000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26452000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9913000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
2190000
CY2018 us-gaap Interest Expense
InterestExpense
1696000
CY2017 us-gaap Interest Expense
InterestExpense
1268000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-218798000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
160469000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
77189000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
213032000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
105292000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
175000
CY2018Q4 fate Cirm Award Liability Noncurrent
CIRMAwardLiabilityNoncurrent
1404000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14808000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64693681
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
52648601
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64693681
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52648601
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4740000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4106000
CY2016 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4402000
CY2018 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2017 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-285396000
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-118000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
494000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-827000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1499000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-42952000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-33462000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
38038000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
187000
CY2016 fate Common Stock Issued During Period Value Private Placement
CommonStockIssuedDuringPeriodValuePrivatePlacement
28797000
CY2016 fate Convertible Preferred Stock Issued During Period Value New Issues
ConvertiblePreferredStockIssuedDuringPeriodValueNewIssues
36289000
CY2016 fate Incentive Bonuses Paid In Value
IncentiveBonusesPaidInValue
121000
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
73154000
CY2017 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
217000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
42979000
CY2017 fate Common Stock Issued During Period Value Private Placement
CommonStockIssuedDuringPeriodValuePrivatePlacement
-13000
CY2017 fate Convertible Preferred Stock Issued During Period Value New Issues
ConvertiblePreferredStockIssuedDuringPeriodValueNewIssues
-26000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2693000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
134791000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6293000
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
6100000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2018 us-gaap Profit Loss
ProfitLoss
-66598000
CY2017 us-gaap Profit Loss
ProfitLoss
-42952000
CY2016 us-gaap Profit Loss
ProfitLoss
-33462000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1204000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
971000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
881000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6293000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3606000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3184000
CY2018 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
76000
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
81000
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
139000
CY2018 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
335000
CY2017 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
25000
CY2016 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-171000
CY2018 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
42000
CY2018 us-gaap Paid In Kind Interest
PaidInKindInterest
373000
CY2017 us-gaap Paid In Kind Interest
PaidInKindInterest
321000
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
492000
CY2018 us-gaap Straight Line Rent
StraightLineRent
-192000
CY2017 us-gaap Straight Line Rent
StraightLineRent
-1085000
CY2016 us-gaap Straight Line Rent
StraightLineRent
7000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
12259000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2105000
CY2016 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2401000
CY2018 fate Common Stock Issued For License Agreements
CommonStockIssuedForLicenseAgreements
6100000
CY2017 fate Cash Payments Included In Loss On Extinguishment Of Debt
CashPaymentsIncludedInLossOnExtinguishmentOfDebt
88000
CY2017 fate Non Cash Loss On Extinguishment Of Debt
NonCashLossOnExtinguishmentOfDebt
30000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
500000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2010000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
428000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
381000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4254000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2511000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1561000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38650000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36817000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29823000
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
18000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2303000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1725000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
457000
CY2018 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
55660000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
1242000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
2314000
CY2016 us-gaap Interest Paid Net
InterestPaidNet
1067000
CY2017 fate Issuance Of Warrants In Connection With Long Term Debt
IssuanceOfWarrantsInConnectionWithLongTermDebt
217000
CY2017 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
39971000
CY2016 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
19675000
CY2018 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
57500000
CY2017 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
31500000
CY2016 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
16000000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-463000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10196000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4114000
CY2018 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
2693000
CY2017 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
205000
CY2016 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
186000
CY2018 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
134577000
CY2017 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
43206000
CY2018 fate Proceeds From Cirm Award
ProceedsFromCIRMAward
3510000
CY2017 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
15000000
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10764000
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7689000
CY2017 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
88000
CY2017 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
10000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
140780000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
47356000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
57737000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
101667000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
343000
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23800000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89074000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
88731000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
64931000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
190741000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (GAAP). The preparation of the Company&#8217;s consolidated financial statements requires it to make estimates and assumptions that impact the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s consolidated financial statements relate to accrued expenses. Although these estimates are based on the Company&#8217;s knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</p>
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments, which potentially subject the Company to a significant concentration of credit risk, consist primarily of cash and cash equivalents, and short-term investments. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits and investments are held. </p>
CY2018 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2018 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2018Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88609000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
227000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
122000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
122000
CY2018 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
more than 50 percent
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21352045
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19994169
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18667458
CY2018 fate Period To Treat Award As Grant If Award Not Treated As Loan
PeriodToTreatAwardAsGrantIfAwardNotTreatedAsLoan
P10Y
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
10495000
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
12000000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2000
CY2017Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10493000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
11997000
CY2018 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2018 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2017 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11450000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7689000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6325000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5139000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
200000
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2938000
CY2017Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1761000
CY2018Q4 fate Accrued Clinical Trial Related Costs Current
AccruedClinicalTrialRelatedCostsCurrent
4729000
CY2017Q4 fate Accrued Clinical Trial Related Costs Current
AccruedClinicalTrialRelatedCostsCurrent
3323000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3259000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2170000
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15000000
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15000000
CY2018Q4 fate Debt Instrument Discount Non Current
DebtInstrumentDiscountNonCurrent
54000
CY2017Q4 fate Debt Instrument Discount Non Current
DebtInstrumentDiscountNonCurrent
192000
CY2018Q4 fate Long Term Debt Net Of Long Term Portion Of Debt Issuance Costs And Discounts
LongTermDebtNetOfLongTermPortionOfDebtIssuanceCostsAndDiscounts
14946000
CY2017Q4 fate Long Term Debt Net Of Long Term Portion Of Debt Issuance Costs And Discounts
LongTermDebtNetOfLongTermPortionOfDebtIssuanceCostsAndDiscounts
14808000
CY2018Q4 fate Long Term Debt Gross Current
LongTermDebtGrossCurrent
2500000
CY2018Q4 fate Debt Instrument Discount Current
DebtInstrumentDiscountCurrent
62000
CY2018Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2300000
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2300000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1300000
CY2018 fate Minimum Annual Payments To Maintain Licenses
MinimumAnnualPaymentsToMaintainLicenses
300000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3720000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6818000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
6313000
CY2018Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1629000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
18480000
CY2018Q4 fate Long Term Debt Maturities Repayments Interest Included In Payments
LongTermDebtMaturitiesRepaymentsInterestIncludedInPayments
2355000
CY2018Q4 fate Long Term Debt Maturities Additional Payments Due On Maturity
LongTermDebtMaturitiesAdditionalPaymentsDueOnMaturity
1125000
CY2018Q4 fate Unamortized Debt Discounts And Debt Issuance Cost
UnamortizedDebtDiscountsAndDebtIssuanceCost
116000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
3019000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3761000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3873000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3989000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
4109000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
22470000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
41221000
CY2018Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
6739000
CY2018Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
10579000
CY2018Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
10186000
CY2018Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
5618000
CY2018Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
4109000
CY2018Q4 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
22470000
CY2018Q4 us-gaap Contractual Obligation
ContractualObligation
59701000
CY2018 fate Early Termination Payment Description
EarlyTerminationPaymentDescription
The Company maintains the right to terminate the lease after October 2025, subject to our delivery to the landlord of twelve months’ prior written notice and an early termination payment of $2.5 million
CY2018 fate Payment For Early Termination Of Lease
PaymentForEarlyTerminationOfLease
2500000
CY2018 us-gaap Dividends
Dividends
0
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
26065733
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
24395281
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-13985000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14603000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-11377000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1620000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1315000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2089000
CY2018 fate Income Tax Reconciliation Permanent Tax Differences
IncomeTaxReconciliationPermanentTaxDifferences
22000
CY2017 fate Income Tax Reconciliation Permanent Tax Differences
IncomeTaxReconciliationPermanentTaxDifferences
795000
CY2016 fate Income Tax Reconciliation Permanent Tax Differences
IncomeTaxReconciliationPermanentTaxDifferences
292000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-307000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
539000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
968000
CY2018 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
3301000
CY2017 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
2934000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
971000
CY2018 fate Income Tax Reconciliation Reserve For Uncertain Tax Positions
IncomeTaxReconciliationReserveForUncertainTaxPositions
1160000
CY2017 fate Income Tax Reconciliation Reserve For Uncertain Tax Positions
IncomeTaxReconciliationReserveForUncertainTaxPositions
1326000
CY2016 fate Income Tax Reconciliation Reserve For Uncertain Tax Positions
IncomeTaxReconciliationReserveForUncertainTaxPositions
2076000
CY2016 fate Income Tax Reconciliation Tax Attribute Limitation
IncomeTaxReconciliationTaxAttributeLimitation
54000
CY2017 fate Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
25280000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
304000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
46000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-74000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
17727000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-9134000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11121000
CY2018Q4 fate Deferred Tax Assets Section59e Amortization
DeferredTaxAssetsSection59eAmortization
19069000
CY2017Q4 fate Deferred Tax Assets Section59e Amortization
DeferredTaxAssetsSection59eAmortization
14365000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30981000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27699000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
9163000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5421000
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1653000
CY2017Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
581000
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
3906000
CY2017Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
594000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1482000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
876000
CY2018Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-1106000
CY2017Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-96000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
67360000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
49632000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
67360000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
49632000
CY2018 fate Cumulative Change In Ownership Percentage
CumulativeChangeInOwnershipPercentage
0.50
CY2018 fate Period For Cumulative Change In Ownership
PeriodForCumulativeChangeInOwnership
P3Y
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3869000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-12497000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
1625000
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
32000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7730000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
4077000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
6000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1798000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
148000
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
199000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13547000
CY2018Q4 fate Unrecognized Tax Benefits Resulting In Net Operating Loss And Tax Credit Carryforward
UnrecognizedTaxBenefitsResultingInNetOperatingLossAndTaxCreditCarryforward
0
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 fate Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Assets And Liabilities Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetsAndLiabilitiesIncomeTaxExpenseBenefit
25300000
CY2009Q1 fate Defined Contribution Plan Minimum Age Of Employee
DefinedContributionPlanMinimumAgeOfEmployee
P21Y
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1026000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1027000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1026000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1661000
CY2018Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2018Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2018Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2018Q4 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
15080000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
20632000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
17718000
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
18402000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-14135000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-19654000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-16782000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-16027000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2017Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2017Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2017Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2017Q4 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2017Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1027000
CY2017Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1026000
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1026000
CY2017Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1027000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
10998000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
10596000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
11366000
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
13271000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-10126000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-9645000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-10684000

Files In Submission

Name View Source Status
0001564590-19-006258-index-headers.html Edgar Link pending
0001564590-19-006258-index.html Edgar Link pending
0001564590-19-006258.txt Edgar Link pending
0001564590-19-006258-xbrl.zip Edgar Link pending
fate-10k_20181231.htm Edgar Link pending
fate-20181231.xml Edgar Link completed
fate-20181231.xsd Edgar Link pending
fate-20181231_cal.xml Edgar Link unprocessable
fate-20181231_def.xml Edgar Link unprocessable
fate-20181231_lab.xml Edgar Link unprocessable
fate-20181231_pre.xml Edgar Link unprocessable
fate-ex1033_244.htm Edgar Link pending
fate-ex1038_245.htm Edgar Link pending
fate-ex107_185.htm Edgar Link pending
fate-ex108_272.htm Edgar Link pending
fate-ex141_186.htm Edgar Link pending
fate-ex211_187.htm Edgar Link pending
fate-ex231_7.htm Edgar Link pending
fate-ex311_8.htm Edgar Link pending
fate-ex321_11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2z3ms11nzja000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending